clinical practice
Pain gain
Opioid prescriptions double
over the past quarter century.
By Conor Burke
N
ew research has found that opioid
prescriptions for non-cancer-
related pain have doubled over the
last 24 years.
Academics from the University of Sydney,
University of Warwick (UK), University of
Notre Dame, University of New South
Wales and Monash University looked at
data from eight countries and evaluated
42 published studies that included more
than five million people with chronic pain
conditions (other than cancer).
The data revealed that between 1991 and
2015, one in three patients were prescribed
an opioid medicine, and in the early studies,
opioid medicines were prescribed to
about 20 per cent of patients experiencing
chronic pain, while the later studies report
rates of more than 40 per cent.
“We noted that a higher proportion of
people were prescribed a strong opioid
medicine such as oxycodone compared
to weak opioid pain-relieving medicines,”
said lead author Dr Stephanie Mathieson,
from USyd’s School of Public Health in the
Faculty of Medicine and Health.
The average age of people prescribed
opioids is 55.7 years of age, but the study’s
authors noted a significant evidence gap in
global data.
The study aimed to establish a baseline
for how commonly opioids are prescribed
for people with chronic pain conditions
(other than cancer). But the authors
discovered a lack of prescription data in
countries outside of the US.
“While we have sufficient data for this
purpose for the US, we have little or no
data for other countries,” they wrote.
In the Australian context, data from
the Australian Institute of Health and
Welfare shows around 3.1 million people
were dispensed opioid prescriptions in
2016–17, and between 2007–08 and
2016–17 there was a 25 per cent rise in
the rate of hospitalisations due to opioid
poisoning.
The rate of opioid deaths also rose by
62 per cent from 2007 to 2016.
Previous research carried out by USyd
has found that opioid prescription for
muscle and joint pain in older people –
aged 60 and older – may offer little benefit
and may in fact increase the risk of harmful
side-effects.
“Our findings show that, in this group,
opioid painkillers have only a small effect
on decreasing pain and improving function,
while the risk of side effects is high,” said
Associate Professor Manuela Ferreira,
senior researcher at the Institute of Bone
and Joint Research.
“Patients experienced around a 7 per
cent decrease in pain compared to placebo
pills, which is considered too small to be of
clinical importance.
“Only small improvements on physical
function was found.
“We also found that older people taking
opioids for musculoskeletal pain are almost
three times more likely to have an adverse
event associated with treatment. The most
common being nausea, constipation,
drowsiness, dizziness, headache and
dry mouth.
“The impact of these side effects on
the older patient can be very significant,
leading to more serious events such as falls
and confusion.” ■
SubScribe for leSS than $2 Per week
The laTesT news for nursing & healThcare professionals
Nursing Review is essential reading for anyone involved in the healthcare
sector in Australia. It provides unrivalled coverage of specialist topics from
features and opinion pieces, to international news and profiles.
• Latest news and resources for all healthcare professionals
• Comprehensive coverage of a diverse range of topics
• Analysis of the major issues facing the health sector as a whole
• Delivered free of charge to your home or place of work monthly
Please call 02 9936 8666 to find out more.
22 | nursingreview.com.au